B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $81

Benzinga · 2d ago
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $81.